(Q36748921)

16 August 2017

1 reference

title

The use of oral fluid for therapeutic drug management: clinical and forensic toxicology (English)

1 reference

16 August 2017

1 reference

Loralie J Langman

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Annals of the New York Academy of Sciences

16 August 2017

published in

1 reference

16 August 2017

volume

1098

1 reference

16 August 2017

page(s)

145-166

1 reference

The role of saliva in drug monitoring

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Factors influencing the saliva/plasma ratio of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Clinical correlates of drugs in saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Oral fluid as a diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Saliva testing for drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Legal issues in oral fluid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Review: Pharmacokinetics of illicit drugs in oral fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Clinical utility of free drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Developmental toxicity of valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Correlation of levetiracetam concentrations between serum and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Topiramate concentration in saliva: an alternative to serum monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Psychomotor performance and real driving performance of outpatients receiving diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Salivary and urinary excretion and plasma-saliva concentration ratios of isoniazid in the presence of Co-administered ciprofloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Can fluconazole concentrations in saliva be used for therapeutic drug monitoring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Relationship between plasma and saliva quinine levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Saliva as an alternative body fluid for therapeutic drug monitoring of the nonnucleoside reverse transcription inhibitor nevirapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

High sensitivity ELISA determination of taxol in various human biological fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Determination of cyclosporine in saliva using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Noninvasive assessment in vivo of hepatic drug metabolism in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

Antipyrine as a model drug to study hepatic drug-metabolizing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

The diagnostic uses of saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1384.001

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1384.001

1 reference

16 August 2017

1 reference